José A. Obeso Inchausti-rekin lankidetzan egindako argitalpenak (39)

2023

  1. Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain

    npj Parkinson's Disease, Vol. 9, Núm. 1

2022

  1. Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology

    Brain, Vol. 145, Núm. 3, pp. 1001-1017

2020

  1. Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates

    Brain : a journal of neurology, Vol. 143, Núm. 5, pp. 1462-1475

  2. Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates

    Science advances, Vol. 6, Núm. 20, pp. eaaz9165

2009

  1. No Lewy pathology in monkeys with over 10 years of severe MPTP parkinsonism

    Movement Disorders, Vol. 24, Núm. 10, pp. 1519-1523

2000

  1. Metabolic effects of nigrostriatal denervation in basal ganglia

    Trends in Neurosciences, Vol. 23, Núm. 10 SUPPL.

1998

  1. [125I]EGF binding in basal ganglia of patients with Parkinson's disease and progressive supranuclear palsy and in MPTP-treated monkeys

    Experimental Neurology, Vol. 154, Núm. 1, pp. 146-156

1997

  1. Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: An in situ hybridization study of cytochrome oxidase subunit I mRNA

    Journal of Neuroscience, Vol. 17, Núm. 2, pp. 765-773

  2. Re-evaluation of the functional anatomy of the basal ganglia. In normal and Parkinsonian states

    Neuroscience

1996

  1. Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase messenger RNA in the pallidum

    Neurology, Vol. 47, Núm. 1, pp. 219-224

  2. Consequences of nigrostriatal denervation on the γ-aminobutyric acidic neurons of substantia nigra pars reticulata and superior colliculus in parkinsonian syndromes

    Neurology, Vol. 46, Núm. 3, pp. 802-809

  3. Effects of L-DOPA-therapy on dopamine D2 receptor mRNA expression in the srtiatum of MPTP-intoxicated parkinsonian monkeys

    Molecular Brain Research, Vol. 42, Núm. 1, pp. 149-155

  4. Glutamic acid decarboxylase mRNA expression in medial and lateral pallidal neurons in the MPTP-treated monkey and patients with Parkinson's disease.

    Advances in neurology, Vol. 69, pp. 209-216

  5. Is dopaminergic cell death accompanied by concomitant nerve plasticity?

    Advances in neurology, Vol. 69, pp. 195-208

  6. Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: A cytochrome oxidase histochemistry study

    Neuroscience, Vol. 71, Núm. 4, pp. 903-912

  7. Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis

    Brain, Vol. 119, Núm. 5, pp. 1717-1727

1995

  1. Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys

    Brain Research, Vol. 691, Núm. 1-2, pp. 115-124

  2. Effects of Nigrostriatal Denervation and L‐Dopa Therapy on the GABAergic Neurons of the Striatum in MPTP‐treated Monkeys and Parkinson's Disease: An In Situ Hybridization Study of GAD67 mRNA

    European Journal of Neuroscience, Vol. 7, Núm. 6, pp. 1199-1209

  3. Effects of l-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum

    Neuroscience, Vol. 68, Núm. 4, pp. 1189-1198

  4. Neurotoxicity induced by prenatal exposure to MPTP on the monoaminergic and peptidergic systems of the marmoset brain

    Experimental Neurology, Vol. 131, Núm. 1, pp. 108-113